Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Arango-Bravo E"'
Autor:
Brau-Figueroa H; National Network of Cancer Records, Instituto Nacional de Cancerología, Mexico City, Mexico., Arango-Bravo E; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico., Castro-Eguiluz D; Consejo Nacional de Ciencia y Tecnología (CONACyT)- Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico., Galicia-Carmona T; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico., Lugo-Alferez LA; Hospital Regional No. 2 El Marques, Instituto Mexicano del Seguro Social, Queretaro, Mexico., Cruz-Bautista I; Research Unit in Metabolic Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Jiménez-Lima R; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico., Cetina-Pérez L; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
Publikováno v:
Cancer research and treatment [Cancer Res Treat] 2022 Apr; Vol. 54 (2), pp. 554-562. Date of Electronic Publication: 2021 Aug 10.
Autor:
Arango Bravo E; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.; Integral Program for the Care of Locally Advanced and Metastatic Cervical Cancer (MICAELA), Instituto Nacional de Cancerología, Mexico City, Mexico., Carmona T; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.; Integral Program for the Care of Locally Advanced and Metastatic Cervical Cancer (MICAELA), Instituto Nacional de Cancerología, Mexico City, Mexico., Castro-Eguiluz D; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico.; Investigadores por México, Consejo Nacional de Ciencia y Tecnología (CONACYT), Mexico City, Mexico., Gallardo-Rincón D; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.; Integral Accessibility Program for the Care of Ovarian and Endometrial Cancer (COE), Instituto Nacional de Cancerología, Mexico City, Mexico., Flores E; Department of Oncology, Hospital Médica Sur, Mexico City, Mexico., Cetina-Pérez LDC; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.; Integral Program for the Care of Locally Advanced and Metastatic Cervical Cancer (MICAELA), Instituto Nacional de Cancerología, Mexico City, Mexico.
Publikováno v:
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2021 Nov 16; Vol. 35 (11), pp. 741-745. Date of Electronic Publication: 2021 Nov 16.
Autor:
Galicia-Carmona T; Department of Clinical Research, Instituto Nacional De Cancerología, Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional De Cancerología, Mexico City, Mexico., Arango-Bravo E; Department of Clinical Research, Instituto Nacional De Cancerología, Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional De Cancerología, Mexico City, Mexico., Serrano-Olvera JA; Department of Medical Oncology, Centro Médico ABC, Mexico City, Mexico., Flores-de La Torre C; Department of Medical Oncology, Centro Estatal De Oncología Campeche INDESALUD, Campeche, Mexico., Cruz-Esquivel I; Department of Surgical Oncology, Centro Estatal De Oncología Campeche INDESALUD, Campeche, Mexico., Villalobos-Valencia R; Oncology Hospital, Centro Médico Siglo XXI, Instituto Mexicano Del Seguro Social (IMSS), Mexico City, Mexico., Morán-Mendoza A; Department of Oncology, UMAE Hospital Ginecoobstetricia, Centro Médico Nacional De Occidente, Instituto Mexicano Del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico., Castro-Eguiluz D; Instituto Nacional De Cancerología, Mexico City, Mexico., Cetina-Pérez L; Department of Clinical Research, Instituto Nacional De Cancerología, Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional De Cancerología, Mexico City, Mexico.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Aug 03; Vol. 17 (8), pp. 2617-2625. Date of Electronic Publication: 2021 Apr 01.
Autor:
Jiménez-Lima R; Faculty of Medicine, Doctorate Program in Medical, Dental and Health Sciences, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Arango-Bravo E; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Galicia-Carmona T; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Lino-Silva LS; Department of Oncologic Pathology, and Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Trejo-Durán GE; Department of Radiotherapy, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Alvarado-Silva C; Department of Medical Oncology, Hospital Juárez de México, Mexico City, Mexico., Castañeda-Renderos OH; Department of Medical Oncology, Hospital Universitario de Saltillo, Coah., Mexico., Vanoye-Carlo EG; Department of Gynecologic Oncology, Hospital General Agustín O'Horan Mérida, Yuc., Mexico., Torre CF; Department of Medical Oncology, Centro Estatal de Oncología Campeche INDESALUD, Camp., Mexico., Dueñas-González A; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Cetina-Pérez L; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion [Rev Invest Clin] 2020; Vol. 72 (4), pp. 231-238.
Autor:
Mlynarczyk-Bonikowska, Beata1 (AUTHOR) beata.mlynarczyk-bonikowska@wum.edu.pl, Rudnicka, Lidia1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7616. 33p.
Autor:
Adeleke, Sola1,2 olusola.adeleke@kcl.ac.uk, Gao, Yujia3, Okoli, Somto4, Choi, Sunyoung5, Ding, Hao6, Galante, Joao R.1, Mikropoulos, Christos7
Publikováno v:
Future Pharmacology. Jun2023, Vol. 3 Issue 2, p488-514. 27p.
Publikováno v:
MedComm; Oct2023, Vol. 4 Issue 5, p1-44, 44p
Publikováno v:
Biology (2079-7737); Jul2023, Vol. 12 Issue 7, p941, 31p
Publikováno v:
Chinese Journal of Cancer Biotherapy; Jul2023, Vol. 30 Issue 7, p541-551, 11p